Acura Pharmaceuticals (ACUR) Stock Price, Forecast & Analysis
USA - NASDAQ:ACUR -
ACUR Key Statistics, Chart & Performance
The current stock price of ACUR is 0.62 null. In the past month the price increased by 6.9%. In the past year, price decreased by -70.19%.
ACUR Latest News, Press Relases and Analysis
About ACUR
Company Profile
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
Company Info
Acura Pharmaceuticals
616 N. NORTH COURT SUITE 120
PALATINE IL 60067
CEO: Robert B. Jones
Phone: 847-705-7709
Acura Pharmaceuticals / ACUR FAQ
What does Acura Pharmaceuticals do?
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
What is the stock price of Acura Pharmaceuticals today?
The current stock price of ACUR is 0.62 null. The price decreased by -20.51% in the last trading session.
What is the dividend status of Acura Pharmaceuticals?
ACUR does not pay a dividend.
How is the ChartMill rating for Acura Pharmaceuticals?
ACUR has a ChartMill Technical rating of 2 out of 10.You can find more details on the Technical Analysis and Fundamental Analysis tabs.
Where is Acura Pharmaceuticals (ACUR) stock traded?
ACUR stock is listed on the Nasdaq exchange.
What is Acura Pharmaceuticals worth?
Acura Pharmaceuticals (ACUR) has a market capitalization of 7.37M null. This makes ACUR a Nano Cap stock.
Who owns Acura Pharmaceuticals?
You can find the ownership structure of Acura Pharmaceuticals (ACUR) on the Ownership tab.
ACUR Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to ACUR. When comparing the yearly performance of all stocks, ACUR is a bad performer in the overall market: 95.27% of all stocks are doing better.
ACUR Financial Highlights
Over the last trailing twelve months ACUR reported a non-GAAP Earnings per Share(EPS) of -0.31. The EPS increased by 25.81% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 100.07% | ||
| ROA | -41.13% | ||
| ROE | -356.34% | ||
| Debt/Equity | 2.52 |